Supplementary Figure S8 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Prognostic value of 90% PSA reduction
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Supplementary Figure S8 from Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer | Synapse